drug · enzyme
patient view →avalglucosidase alfa
Phase 3updated 2mo agoby $SNY Sanofi🔗 ChEMBL
Phase 3community read0 votes
Enzyme drug with a maximum clinical stage of Approval (across all indications), with an approval for glycogen storage disease ii and glycogen storage disease due to acid maltase deficiency and 1 investigational indication.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that